363 related articles for article (PubMed ID: 35711437)
1. Comprehensive Analysis of a Cancer-Immunity Cycle-Based Signature for Predicting Prognosis and Immunotherapy Response in Patients With Colorectal Cancer.
Hou Y; Zhang R; Zong J; Wang W; Zhou M; Yan Z; Li T; Gan W; Lv S; Zeng Z; Yang M
Front Immunol; 2022; 13():892512. PubMed ID: 35711437
[TBL] [Abstract][Full Text] [Related]
2. Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients.
Zhang F; Zhang R; Zong J; Hou Y; Zhou M; Yan Z; Li T; Gan W; Lv S; Yang L; Zeng Z; Zhao W; Yang M
Front Immunol; 2023; 14():1279789. PubMed ID: 37928532
[TBL] [Abstract][Full Text] [Related]
3. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
Front Immunol; 2022; 13():951455. PubMed ID: 36189298
[TBL] [Abstract][Full Text] [Related]
4. Developing an m5C regulator-mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer.
Zhang R; Gan W; Zong J; Hou Y; Zhou M; Yan Z; Li T; Lv S; Zeng Z; Wang W; Zhang F; Yang M
Front Immunol; 2023; 14():1054700. PubMed ID: 36911744
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a TNF Family-Based Signature for Predicting Prognosis, Tumor Immune Characteristics, and Immunotherapy Response in Colorectal Cancer Patients.
Xiao Z; Nie K; Han T; Cheng L; Zhang Z; Peng W; Shi D
J Immunol Res; 2021; 2021():6439975. PubMed ID: 34541005
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a circular RNA regulatory stemness-related gene pair signature for predicting prognosis and therapeutic response in colorectal cancer.
Chen Q; Tang P; Huang H; Qiu X
Front Immunol; 2022; 13():934124. PubMed ID: 35958575
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
8. Identification and Validation of the Glycolysis and Immune-related Gene Signature for Prognosis in Colorectal Cancer.
Jiang M; Liu Y; Xu J; Xu Z; Ye T; Li S; Jiang C
Anticancer Res; 2024 Jan; 44(1):117-131. PubMed ID: 38159970
[TBL] [Abstract][Full Text] [Related]
9. An immune landscape based prognostic signature predicts the immune status and immunotherapeutic responses of patients with colorectal cancer.
Li M; Li W; Yang X; Wang H; Peng Y; Yin J; Lu Y; Liu L; Shang J; Zhao Q
Life Sci; 2020 Nov; 261():118368. PubMed ID: 32888940
[TBL] [Abstract][Full Text] [Related]
10. An immune-related gene prognostic index for predicting prognosis in patients with colorectal cancer.
Li C; Wirth U; Schardey J; Ehrlich-Treuenstätt VV; Bazhin AV; Werner J; Kühn F
Front Immunol; 2023; 14():1156488. PubMed ID: 37483596
[TBL] [Abstract][Full Text] [Related]
11. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
12. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer.
Zheng H; Liu H; Ge Y; Wang X
Cancer Cell Int; 2021 Oct; 21(1):552. PubMed ID: 34670584
[TBL] [Abstract][Full Text] [Related]
13. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
[TBL] [Abstract][Full Text] [Related]
14. A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer.
Chen S; Wang Y; Wang B; Zhang L; Su Y; Xu M; Zhang M
PLoS One; 2021; 16(10):e0258741. PubMed ID: 34699544
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of endoplasmic reticulum stress in colorectal cancer for predicting prognosis and developing treatment options.
Geng J; Guo Y; Xie M; Li Z; Wang P; Zhu D; Li J; Cui X
Cancer Med; 2023 May; 12(10):12000-12017. PubMed ID: 36999888
[TBL] [Abstract][Full Text] [Related]
16. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
[TBL] [Abstract][Full Text] [Related]
17. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
[TBL] [Abstract][Full Text] [Related]
18. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
[TBL] [Abstract][Full Text] [Related]
19. Construction of a Novel Immune-Related mRNA Signature to Predict the Prognosis and Immune Characteristics of Human Colorectal Cancer.
Li J; Han T; Wang X; Wang Y; Chen X; Chen W; Yang Q
Front Genet; 2022; 13():851373. PubMed ID: 35401707
[No Abstract] [Full Text] [Related]
20. Cancer-associated fibroblast-related gene signatures predict survival and drug response in patients with colorectal cancer.
Zhang L; Xu C; Wang SH; Ge QW; Wang XW; Xiao P; Yao QH
Front Genet; 2022; 13():1054152. PubMed ID: 36506313
[No Abstract] [Full Text] [Related]
[Next] [New Search]
